Gil Blum
Stock Analyst at Needham
(3.45)
# 944
Out of 4,711 analysts
316
Total ratings
39.67%
Success rate
6.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GERN Geron | Reiterates: Buy | $6 | $3.49 | +71.92% | 19 | Dec 13, 2024 | |
| RXRX Recursion Pharmaceuticals | Reiterates: Buy | $11 | $6.03 | +82.42% | 20 | Dec 11, 2024 | |
| TCRX TScan Therapeutics | Reiterates: Buy | $11 | $2.97 | +270.37% | 5 | Dec 11, 2024 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $29 | $19.83 | +46.24% | 21 | Dec 10, 2024 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $75.54 | +39.00% | 23 | Dec 10, 2024 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $2.29 | +336.68% | 25 | Dec 9, 2024 | |
| RNAC Cartesian Therapeutics | Reiterates: Buy | $41 | $19.02 | +115.56% | 10 | Dec 3, 2024 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $205 → $202 | $118.97 | +69.79% | 25 | Nov 27, 2024 | |
| RCKT Rocket Pharmaceuticals | Reiterates: Buy | $52 | $11.56 | +349.83% | 18 | Nov 19, 2024 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $1.68 | - | 5 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $12.46 | +84.59% | 12 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.15 | - | 15 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.85 | +224.32% | 23 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $11.11 | +107.02% | 3 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.35 | +108.96% | 13 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $11 | $2.37 | +364.14% | 14 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $71 | $28.33 | +150.66% | 10 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $9.80 | - | 4 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $84 | $40.72 | +106.29% | 17 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.19 | +740.34% | 13 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.97 | +312.37% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.92 | +550.05% | 12 | Apr 12, 2024 |
Geron
Dec 13, 2024
Reiterates: Buy
Price Target: $6
Current: $3.49
Upside: +71.92%
Recursion Pharmaceuticals
Dec 11, 2024
Reiterates: Buy
Price Target: $11
Current: $6.03
Upside: +82.42%
TScan Therapeutics
Dec 11, 2024
Reiterates: Buy
Price Target: $11
Current: $2.97
Upside: +270.37%
Nurix Therapeutics
Dec 10, 2024
Reiterates: Buy
Price Target: $29
Current: $19.83
Upside: +46.24%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $75.54
Upside: +39.00%
Autolus Therapeutics
Dec 9, 2024
Reiterates: Buy
Price Target: $10
Current: $2.29
Upside: +336.68%
Cartesian Therapeutics
Dec 3, 2024
Reiterates: Buy
Price Target: $41
Current: $19.02
Upside: +115.56%
Sarepta Therapeutics
Nov 27, 2024
Maintains: Buy
Price Target: $205 → $202
Current: $118.97
Upside: +69.79%
Rocket Pharmaceuticals
Nov 19, 2024
Reiterates: Buy
Price Target: $52
Current: $11.56
Upside: +349.83%
Fate Therapeutics
Nov 19, 2024
Reiterates: Hold
Price Target: n/a
Current: $1.68
Upside: -
Nov 15, 2024
Reiterates: Buy
Price Target: $23
Current: $12.46
Upside: +84.59%
Nov 14, 2024
Reiterates: Hold
Price Target: n/a
Current: $1.15
Upside: -
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.85
Upside: +224.32%
Nov 13, 2024
Reiterates: Buy
Price Target: $23
Current: $11.11
Upside: +107.02%
Nov 12, 2024
Reiterates: Buy
Price Target: $7
Current: $3.35
Upside: +108.96%
Nov 8, 2024
Maintains: Buy
Price Target: $13 → $11
Current: $2.37
Upside: +364.14%
Nov 7, 2024
Maintains: Buy
Price Target: $78 → $71
Current: $28.33
Upside: +150.66%
Nov 7, 2024
Reiterates: Hold
Price Target: n/a
Current: $9.80
Upside: -
Nov 6, 2024
Reiterates: Buy
Price Target: $84
Current: $40.72
Upside: +106.29%
Oct 23, 2024
Reiterates: Buy
Price Target: $10
Current: $1.19
Upside: +740.34%
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.97
Upside: +312.37%
Apr 12, 2024
Reiterates: Buy
Price Target: $6
Current: $0.92
Upside: +550.05%